As for AD biomarkers, only the presymptomatic PREVENT-AD cohort display significant association between the vesicle amine transport 1 like (VAT1L) variant and pTau181 (p = 0.006) as well as total tau levels in the CSF (p = 0.005). The gene discussed is MAPT; the disease is Alzheimer disease.